This website is intended for patients & providers in the USA only. Prescribing Information.
This website is intended for patients & providers outside of the USA. Prescribing Information.

Latest News

September 04, 2019

Bioness Announces Preliminary European Post-Approval Results of StimRouter® Neuromodulation System for the Treatment of Overactive Bladder at the 49th International Continence Society Annual Meeting

continue reading
February 18, 2019

Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Overactive Bladder (OAB)

continue reading